In a report published Monday, Sterne Agee Group reiterated its Buy rating and $48.00 price target on Metlife MET.
Sterne Agee noted, “While we believe it's likely that MET will receive another extension from the Federal Reserve with respect to refiling its stress test data under the 2012 CCAR examination, as of this morning, there is no confirmation from the company that such an extension has been granted. Recall MET was originally granted an extension to Sept. 30th.”
Metlife closed on Friday at $34.46.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in